HIV drug could be made for just $40 a year for every patient

Published: August 10, 2024

abstract-business-code-270348

Article URL: https://www.theguardian.com/global-development/article/2024/jul/23/hiv-aids-prevention-vaccine-lenacapavir-sunlenca-pharmaceuticals-gilead-generic-licensing

Comments URL: https://news.ycombinator.com/item?id=41206667

Points: 1

# Comments: 0